Cargando…
Corrigendum to “Assessment of trivalent live influenza vaccines in MDCK cell line” [MethodsX 8 (2021) 101442]
Autores principales: | Landgraf, G., Desheva, Y.A., Rudenko, L.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563684/ https://www.ncbi.nlm.nih.gov/pubmed/34754796 http://dx.doi.org/10.1016/j.mex.2021.101526 |
Ejemplares similares
-
Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021) -
Corrigendum to “Detection of BRAF mutations from solid tumors using Tumorplex™ technology” [MethodsX 2 (2015), 316–322]
por: Yo, Jacob, et al.
Publicado: (2016) -
IRF7-deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production
por: Mayuramart, Oraphan, et al.
Publicado: (2022) -
Data generated from three quantitative mass spectral methods for the analysis of trivalent influenza vaccine antigens are compared
por: Smith, Daryl G.S., et al.
Publicado: (2016) -
Corrigendum to ‘‘Sampling protocol for the determination of nutrients and contaminants in fish and other seafood – The EAF-Nansen programme” [MethodsX 7 (2020) 101063]
por: Moxness Reksten, Amalie, et al.
Publicado: (2021)